Ha Kung Wong practices general intellectual property law with an emphasis on complex patent and trade secret litigation as well as intellectual property transactions and contract negotiations for mergers, acquisitions, vendor agreements and collaborations in pharmaceuticals, biologics, chemistry and medical devices.
Cases Ha Kung has litigated include those related to proton pump inhibitors, anti-epileptic drugs, anti-tussives, ADHD medications, injectable microspheres, RNAi products and other pharmaceuticals. Ha Kung also has extensive experience with inter partes review, post grant review, intellectual property counseling, pre-suit investigations, licensing and due diligence, including patent strength and freedom-to-operate analyses.
In this program, Venable LLP Partners Ha Kung Wong, Peter Shapiro, and Dennis McMahon will review the unique aspects of conducting IP due diligence in the Artificial Intelligence ("AI") space, whether you are simply evaluating an IP portfolio or eval...
In this program, Venable LLP Partner Ha Kung Wong will review the basics of conducting IP due diligence, whether you are simply evaluating an IP portfolio or evaluating a potential company acquisition or asset divestment, including how to identify an...